Content

What is HEMANGEOL (propranolol hydrochloride oral solution)?

HEMANGEOL is a prescription medicine used to treat proliferating infantile hemangioma that requires treatment with a medicine that spreads throughout the body.

Important Safety Information for HEMANGEOL

Do not give HEMANGEOL to your child if your child:
  • was born prematurely and has not reached the corrected age of 5 weeks
  • weighs less than 4 ½ pounds
  • is allergic to propranolol or any of the other ingredients in HEMANGEOL
  • has asthma or a history of breathing problems
  • has a heart problem, slow heart rate (less than 80 heart beats per minute), very low blood pressure
  • is at risk for low blood sugar, for example is vomiting or unable to take feedings
  • has high blood pressure caused by a tumor on the adrenal gland, called “pheochromocytoma”

Tell the doctor about all medicines your child is taking, or all the medicines you are taking if you are breastfeeding.

HEMANGEOL can cause serious side effects, including:
Low blood sugar (hypoglycemia),
especially if your child is not taking feedings, or is vomiting. HEMANGEOL may make it more diifcult to recognize the signs and symptoms of low blood sugar in your child. To help reduce the risk of low blood sugar with HEMANGEOL, give HEMANGEOL during or shortly after feeding your child. Feed your child regulary during treatment. Tell your doctor if your child has a poor appetite. If your child is not taking feedings, due to an illness or vomiting, do not give HEMANGEOL until your child is taking feedings normally again.

If your child has any of the signs or symptoms of low blood sugar listed below during treatment with HEMANGEOL, stop giving your child HEMANGEOL and call your doctor or go to the nearest emergency room right away.

Signs or symptoms of low blood sugar include:
pale, blue or purple skin color, sweating, irritability, crying for no apparent reason, irregular or fast heartbeat, poor feeding, low body temperature, unusual sleepiness, seizures, breathing stops for short periods of time, and loss of consciousness

Other serious side effects can include:
  • New or worsening slow heart rate (bradycardia) or low blood pressure (hypotension).
  • Breathing problems or wheezing.
  • Stroke. HEMANGEOL may increase the risk of stroke in certain children who have severe problems with the blood vessels in their brain, particularly if your child has a large hemangioma that affects the face or head.
Call your doctor or go to the nearest hospital emergency room if your child has:
  • pale skin color, slow or uneven heartbeats, arms or legs feel cold, blue or purple skin color, or fainting.
  • breathing problems or wheezing during treatment with HEMANGEOL.

The most common side effects include: sleep problems, worsening respiratory tract infections, diarrhea, and vomiting.

These are not all the possible side effects of HEMANGEOL. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Full Prescribing Information and Medication Guide.

Legal Terms and Conditions

Acceptance of terms and conditions

By using this website you agree to be bound and to abide by these Terms and Conditions of Use (“Terms”). Pierre Fabre Pharmaceuticals, Inc. (“we,” “us,” or “our”) reserve the right to amend these terms at any time and in any manner by posting the amended terms on this website. In addition to providing, reviewing, and understanding our website’s disclaimer, please check these terms periodically for changes. Your continued use of this website reaffirms your acceptance of, and your agreement to be bound and to abide by, these terms as amended. If you do not wish to be bound by these terms, you may not use this website.

Illegal use prohibited

This website may be used only for lawful purposes. The website may not be used to transmit, retransmit, distribute, post, or store any material, that, in the sole judgment of Pierre Fabre Pharmaceuticals, Inc. (i) is in violation of any local, state, federal, or international law or regulation; (ii) is in violation of any rights of any person including rights protected by copyright, trade secret, patent, or other intellectual property or similar laws or regulations; (iii) is threatening, obscene, indecent, defamatory, profane, pornographic, or otherwise objectionable information of any kind, including material that restricts a civil liberty; or (iv) material that violates export control laws. You may not use this website for the misappropriation of consumer information.

Website content

This website contains information, images, and other material (together, the “Content”) that are protected by copyrights, trademarks, or other proprietary rights. You may not modify, remove, delete, augment, publish, create derivative works from, or in any way exploit any of the Content.

Links

This website may include links to other websites. You enter linked websites at your own risk. Pierre Fabre Pharmaceuticals, Inc. is not responsible for the content of such websites or any link contained in a linked website and does not endorse any linked website. Pierre Fabre Pharmaceuticals, Inc. is not responsible or liable for any products, services, or content on or available from such websites. Pierre Fabre Pharmaceuticals, Inc. shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with use of or reliance on any such products, services or content available on such external websites.

No warranties

You expressly agree that use of this website is at your own risk. Pierre Fabre Pharmaceuticals, Inc. expressly disclaims all warranties of any kind, whether expressed or implied, including, but not limited to, the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. Pierre Fabre Pharmaceuticals, Inc. does not make any warranty as to the results that may be obtained from the use of the products, services, and information, or as to the accuracy or reliability of any products, services and information obtained through this website. It is solely your responsibility to evaluate the quality and merchantability of all products, services, and information provided through this website.

Limitation of liability

Pierre Fabre Pharmaceuticals, Inc. shall not be liable for any direct, indirect, incidental, special, or consequential damages resulting from the use or inability to use this website or from the products, services, and information purchased or obtained through Pierre Fabre Pharmaceuticals, Inc., even if Pierre Fabre Pharmaceuticals, Inc. has been advised of the possibility of such damages.

Miscellaneous

This agreement shall be governed by and construed in accordance with the laws of the State of New Jersey without regard to any choice of law principles that could result in the application of the laws of any other jurisdiction. All actions relating to or in connection with this Agreement are to be venued in the state or federal courts of New Jersey.

Pierre Fabre Pharmaceuticals, Inc. shall not be liable for delays or failure to meet its obligations pursuant to this Agreement due to causes beyond the party’s reasonable control, provided the nonperforming party promptly notifies the other party of the nonperformance and takes all reasonable steps to recommence performance promptly.

If any provision of these terms is held to be invalid or unenforceable, the remainder of the provisions shall remain in full force and effect.

What is HEMANGEOL (propranolol hydrochloride oral solution)?

HEMANGEOL is a prescription medicine used to treat proliferating infantile hemangioma that requires treatment with a medicine that spreads throughout the body.

Important Safety Information for HEMANGEOL

Do not give HEMANGEOL to your child if your child:
  • was born prematurely and has not reached the corrected age of 5 weeks
  • weighs less than 4 ½ pounds
  • is allergic to propranolol or any of the other ingredients in HEMANGEOL
  • has asthma or a history of breathing problems
  • has a heart problem, slow heart rate (less than 80 heart beats per minute), very low blood pressure
  • is at risk for low blood sugar, for example is vomiting or unable to take feedings
  • has high blood pressure caused by a tumor on the adrenal gland, called “pheochromocytoma”

Tell the doctor about all medicines your child is taking, or all the medicines you are taking if you are breastfeeding.

HEMANGEOL can cause serious side effects, including:
Low blood sugar (hypoglycemia),
especially if your child is not taking feedings, or is vomiting. HEMANGEOL may make it more diifcult to recognize the signs and symptoms of low blood sugar in your child. To help reduce the risk of low blood sugar with HEMANGEOL, give HEMANGEOL during or shortly after feeding your child. Feed your child regulary during treatment. Tell your doctor if your child has a poor appetite. If your child is not taking feedings, due to an illness or vomiting, do not give HEMANGEOL until your child is taking feedings normally again.

If your child has any of the signs or symptoms of low blood sugar listed below during treatment with HEMANGEOL, stop giving your child HEMANGEOL and call your doctor or go to the nearest emergency room right away.

Signs or symptoms of low blood sugar include:
pale, blue or purple skin color, sweating, irritability, crying for no apparent reason, irregular or fast heartbeat, poor feeding, low body temperature, unusual sleepiness, seizures, breathing stops for short periods of time, and loss of consciousness

Other serious side effects can include:
  • New or worsening slow heart rate (bradycardia) or low blood pressure (hypotension).
  • Breathing problems or wheezing.
  • Stroke. HEMANGEOL may increase the risk of stroke in certain children who have severe problems with the blood vessels in their brain, particularly if your child has a large hemangioma that affects the face or head.
Call your doctor or go to the nearest hospital emergency room if your child has:
  • pale skin color, slow or uneven heartbeats, arms or legs feel cold, blue or purple skin color, or fainting.
  • breathing problems or wheezing during treatment with HEMANGEOL.

The most common side effects include: sleep problems, worsening respiratory tract infections, diarrhea, and vomiting.

These are not all the possible side effects of HEMANGEOL. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Full Prescribing Information and Medication Guide.